Europe Ophthalmic Drugs & Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers European Ophthalmology Pharmaceutical Companies and the market is Segmented by Product (Devices, and Drugs), Disease (Glaucoma, Cataract, Age-related Macular Degeneration, Inflammatory Diseases, Refractive Disorders, and Other Diseases), and Geography (Germany, UK, France, Italy, Spain and the Rest of Europe). The report offers the value (in USD Million) for the above segments.

Europe Ophthalmic Drugs & Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Europe Ophthalmic Drugs and Devices Industry Overview

The Europe ophthalmology drug and devices market is fragmented due to the presence of fewer companies at the global and regional levels. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known as Alcon Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, Essilor International SA, Haag-Streit Group, Johnson & Johnson, Nidek Co. Ltd, Topcon Corporation, Ziemer Group AG, Staar Surgical, Inc., Novartis International AG, Pfizer Inc, and Roche Holding Ltd.

Europe Ophthalmic Drugs and Devices Market Leaders

  1. Topcon Corporation

  2. Johnson & Johnson

  3. Carl Zeiss Meditec AG

  4. Pfizer

  5. Nidek Co. Ltd

  6. *Disclaimer: Major Players sorted in no particular order
Europe Ophthalmology Drug and Device Market Concentration

Europe Ophthalmic Drugs and Devices Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?